Related Experiment Videos
Nonalcoholic fatty liver disease.
1Division of Gastroenterology, Children's Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA. maureen.jonas@tch.harvard.edu
Adolescent Medicine Clinics
|July 24, 2004
Summary
Childhood nonalcoholic fatty liver disease (NAFLD) is increasingly recognized, often linked to obesity. This condition, including nonalcoholic steatohepatitis (NASH), has limited treatment options and can progress to cirrhosis.
Area of Science:
- Hepatology
- Pediatric Gastroenterology
- Metabolic Disorders
Background:
- Nonalcoholic fatty liver disease (NAFLD) is a spectrum of liver conditions, ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), which can lead to cirrhosis.
- While not fully understood, childhood NAFLD prevalence is higher than previously thought, correlating with rising childhood obesity rates.
- The pathogenesis of NASH involves a 'two-hit' process: disrupted lipid metabolism, insulin resistance with hyperinsulinemia, and triglyceride toxicity to hepatocytes.
Purpose of the Study:
- To review the current understanding of nonalcoholic fatty liver disease (NAFLD) in children.
- To highlight the association between childhood obesity and the increasing frequency of fatty liver diagnoses.
- To discuss the proposed pathogenesis of nonalcoholic steatohepatitis (NASH) and its potential progression.
Main Methods:
- Literature review of existing studies on childhood NAFLD.
- Analysis of the relationship between obesity prevalence and NAFLD diagnosis in pediatric populations.
- Examination of the proposed etiological factors for NASH development.
Main Results:
- NAFLD is recognized more frequently in children, strongly associated with the rising prevalence of childhood obesity.
- The spectrum of NAFLD includes simple steatosis and NASH, with NASH posing a risk for progression to cirrhosis.
- Key pathogenic factors for NASH include disturbed lipid homeostasis, insulin resistance, and direct triglyceride toxicity to liver cells.
Conclusions:
- Childhood NAFLD is an emerging health concern linked to the obesity epidemic.
- Understanding the pathogenesis of NASH is crucial for developing effective interventions.
- Current therapeutic strategies for NAFLD and NASH in children are limited, necessitating further research.